Trial · NCT07910487
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
NCT07910487, Not applicable, Not yet recruiting, Beni-Suef University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery. Trials, record NCT07910487. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910487
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
- NCT number
- NCT07910487
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 64 participants, estimated
- Lead sponsor
- Beni-Suef University
- Conditions
- Femur Neck Fracture, Hip Fractures, Postoperative Pain
- Interventions
- Pericapsular Nerve Group Block, Lumbar Erector Spinae Plane Block
- First posted
- 2026-11-02
- Last updated
- 2026-11-04
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Postoperative Pain Score on Movement at 12 Hours | 12 hours after the end of surgery | Pain intensity assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain is evaluated during gentle passive leg movement (flexion or rotation) of the operated limb. |
| Secondary | Postoperative Pain Scores at Rest and Movement at Specified Time Points | 30 minutes, 2 hours, 6 hours, 24 hours, and 48 hours after surgery | Pain intensity measured using the Numeric Rating Scale (NRS 0-10, where 0 = no pain and 10 = worst imaginable pain) at rest and during gentle passive movement of the operated limb. |
| Secondary | Cumulative Opioid Consumption in the First 24 Hours | First 24 hours postoperatively | Total dose of intravenous pethidine (meperidine) administered as rescue analgesia in milligrams (mg). |
| Secondary | Time to First Rescue Analgesic Request | Up to 48 hours postoperatively | Duration of time measured in hours from the end of surgery until the patient requests the first dose of rescue IV pethidine. |
| Secondary | Quadriceps Motor Function (Knee Extension Strength) | At 6, 12, and 24 hours postoperatively | Evaluation of ipsilateral quadriceps muscle strength using the Medical Research Council (MRC) scale, ranging from 0 (no movement) to 5 (normal strength). Motor weakness is defined as an MRC grade ≤ 3/5. |
| Secondary | Incidence of Block-Related Complications and Opioid-Related Adverse Events | Up to 48 hours postoperatively | Percentage of participants experiencing adverse events including postoperative nausea and vomiting (PONV), pruritus, urinary retention, hypotension, bradycardia, signs of local anesthetic systemic toxicity (LAST), hematoma, injection site infection, neurological deficit/nerve injury, or falls. |
| Secondary | Length of Hospital Stay | From date of surgery until hospital discharge (up to approximately 30 days) | Duration of time from surgery completion until discharge from the hospital, measured in total days. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910487
GET https://conductscience.org/api/trials/v1/NCT07910487/registered